Transgenomic Obtains Exclusive License to Mitochondrial DNA Damage Detection ... (Pharmacology and Chemical Biology and is...)

Transgenomic Obtains Exclusive License to Mitochondrial DNA Damage Detection Technology

Date:12/4/2008

Pharmacology and Chemical Biology, and is Leader of the Program in Molecular and Cell Biology UPCI.

About UNC Health Care and the University of North Carolina School of Medicine

The UNC Health Care System is a not-for-profit integrated health care system owned by the state of North Carolina and based in Chapel Hill. It exists to further the teaching mission of the University of North Carolina and to provide state-of-the-art patient care. UNC Health Care is comprised of UNC Hospitals, which is ranked among the top 50 in the nation in six specialties by U.S. News & World Report and ranked one of the country's 41 best on the Leapfrog 2007 Top Hospitals list; the UNC School of Medicine, a nationally eminent research institution; community practices; home health and hospice services in seven central North Carolina counties; and Rex Healthcare and its provider network in Wake County; and Chatham Hospital in Siler City.

Dr. Runge is president of UNC Physicians and Associates for UNC Health Care in addition to being chair of the Department of Medicine at the University of North Carolina School of Medicine.

Transgenomic Cautionary Statements

Certain statements in this press release constitute "forward-looking statements" of Transgenomic within the meaning of the Private Securities Litigation Reform Act of 1995, which involve known and unknown risks, uncertainties and other factors that may cause our actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Forward-looking statements include, but are not limited to, those with respect to management's current views and estimates of future economic circumstances, industry conditions, company performance and financial results, including the ability of the Company to grow its involvement in the diagnostic products and services
'/>"/>

0

GOOD

Page: 1 2 3 4 5 6
Related medicine news :

1. Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc.
2. China Sky One Medical, Inc. Obtains Production Approval for Two New Drugs
3. William F. McMurry - Lead Class Counsel Obtains $16.4 Million Settlement for Elderly Clients
4. China Medicine Corporation Obtains Australian Patent for rADTZ
5. DRAXIS Obtains Final Order for Proposed Arrangement
6. DRAXIS Obtains Interim Order for Proposed Arrangement
7. VIE Healthcare Expands Its Operations in the Midwest, and Obtains First Local Client
8. Aspreva obtains shareholder approval for acquisition by Galenica
9. Patient Lift Manufacturer, Medcare Products, Obtains Women-Owned Certification
10. GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
11. BET Networks Joins the International Call to Stop the Spread of HIV on World AIDS Day Monday, December 1 with a Special Episode of 106 & PARK Followed by BET News Exclusive ARE YOU POSITIVE?

Post Your Comments:

Transgenomic Obtains Exclusive License to Mitochondrial DNA Damage Detection ...(Pharmacology and Chemical Biology and is...),Health